Rifampin vs. Isoniazid for Latent TB: Adverse Events and Adherence
Serious adverse events occurred less frequently and adherence was better with 4 months of rifampin than with 9 months of isoniazid.
Welcome to Journal Watch. The content you requested requires sign in with a username and password.
Sign In
Sign Up
Print subscribers
Activate your free online account for full access to all site content and features.
Other visitors
Subscribe for full access to all site content and features. ($99/year)
Purchase a site pass for full access to all articles. ($19/7 days)
Or, simply register for free access to email alerts, site features, and article archives. (FREE)